Cargando…

Markers of Field Cancerization: Proposed Clinical Applications in Prostate Biopsies

Field cancerization denotes the occurrence of genetic, epigenetic, and biochemical aberrations in structurally intact cells in histologically normal tissues adjacent to cancerous lesions. This paper tabulates markers of prostate field cancerization known to date and discusses their potential clinica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trujillo, Kristina A., Jones, Anna C., Griffith, Jeffrey K., Bisoffi, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3361299/ https://www.ncbi.nlm.nih.gov/pubmed/22666601 http://dx.doi.org/10.1155/2012/302894

Ejemplares similares

Association and regulation of protein factors of field effect in prostate tissues
por: Gabriel, Kristin N., et al.
Publicado: (2016)

Prostate Field Cancerization: Deregulated Expression of Macrophage Inhibitory Cytokine 1 (MIC-1) and Platelet Derived Growth Factor A (PDGF-A) in Tumor Adjacent Tissue
por: Jones, Anna C., et al.
Publicado: (2015)

Blood-based liquid biopsies for prostate cancer: clinical opportunities and challenges
por: Trujillo, Blanca, et al.
Publicado: (2022)

DNA methylation in repeat negative prostate biopsies as a marker of missed prostate cancer
por: Fiano, Valentina, et al.
Publicado: (2019)

Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications
por: Boire, Adrienne, et al.
Publicado: (2019)

Clinical Applications of Liquid Biopsy in Prostate Cancer: From Screening to Predictive Biomarker
por: Ionescu, Filip, et al.
Publicado: (2022)

Magnetic Resonance Imaging–targeted Prostate Biopsy Compared with Systematic Prostate Biopsy in Biopsy-naïve Patients with Suspected Prostate Cancer
por: Alkema, Nicolette G., et al.
Publicado: (2022)

Role of Prostate-Specific Antigen Change Ratio at Initial Biopsy as a Novel Decision-Making Marker for Repeat Prostate Biopsy
por: Lee, Jung Gon, et al.
Publicado: (2012)

Prognostic Histopathological and Molecular Markers on Prostate Cancer Needle-Biopsies: A Review
por: Hoogland, A. Marije, et al.
Publicado: (2014)

Application of single-point prostate biopsy in elderly patients with highly suspected prostate cancer
por: Luan, Yang, et al.
Publicado: (2022)

Discoveries and application of prostate-specific antigen, and some proposals to optimize prostate cancer screening
por: Tokudome, Shinkan, et al.
Publicado: (2016)

Effects of Caffeine on Metabolism and Mitochondria Biogenesis in Rhabdomyosarcoma Cells Compared with 2,4-Dinitrophenol
por: Vaughan, Roger A., et al.
Publicado: (2012)

Conjugated linoleic acid or omega 3 fatty acids increase mitochondrial biosynthesis and metabolism in skeletal muscle cells
por: Vaughan, Roger A, et al.
Publicado: (2012)

Immunohistochemistry for Prostate Biopsy—Impact on Histological Prostate Cancer Diagnoses and Clinical Decision Making
por: Mandel, Philipp, et al.
Publicado: (2021)

Office-Based, Single-Sided, Low-Field MRI-Guided Prostate Biopsy
por: Satya, Poorvi, et al.
Publicado: (2022)

Effectiveness of Bi-Parametric MR/US Fusion Biopsy for Detecting Clinically Significant Prostate Cancer in Prostate Biopsy Naïve Men
por: Kim, Young Joo, et al.
Publicado: (2019)

Effect of information on prostate biopsy history on biopsy outcomes in the era of MRI-targeted biopsies
por: Lantz, Anna, et al.
Publicado: (2020)

Validation of an epigenetic field of susceptibility to detect significant prostate cancer from non-tumor biopsies
por: Yang, Bing, et al.
Publicado: (2019)

Optimal biopsy approach for detection of clinically significant prostate cancer
por: Ippoliti, Simona, et al.
Publicado: (2022)

Indications for a second prostate biopsy in patients suspected with prostate cancer after an initial negative prostate biopsy
por: Lee, Kwang Suk, et al.
Publicado: (2017)

Optimizing the clinical utility of PCA3 to diagnose prostate cancer in initial prostate biopsy
por: Rubio-Briones, Jose, et al.
Publicado: (2015)

Comparison of clinically significant prostate cancer detection by MRI cognitive biopsy and in-bore MRI-targeted biopsy for naïve biopsy patients
por: Zhang, Kai, et al.
Publicado: (2020)

Clinical Applications of Synovial Biopsy
por: Manzo, Antonio, et al.
Publicado: (2019)

Biopsy interpretation of the prostate
por: Epstein, Jonathan I.

Prostate biopsy interpretation
por: Epstein, Jonathan I.

Treatment of human muscle cells with popular dietary supplements increase mitochondrial function and metabolic rate
por: Vaughan, Roger A, et al.
Publicado: (2012)

Initial phantom studies for an office-based low-field MR system for prostate biopsy
por: Chiragzada, Selin, et al.
Publicado: (2021)

The Clinical Value of Performing an MRI before Prostate Biopsy
por: Choi, Myung Sun, et al.
Publicado: (2011)

Clinical Applications of Liquid Biopsy in Gastric Cancer
por: Chivu-Economescu, Mihaela, et al.
Publicado: (2021)

Clinical application of liquid biopsy in cancer patients
por: Chang, Chieh-Min, et al.
Publicado: (2022)

Sensor-Integrated Microfluidic Approaches for Liquid Biopsies Applications in Early Detection of Cancer
por: Sierra, Jessica, et al.
Publicado: (2020)

Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as a Liquid Biopsy Marker in Colorectal Cancer
por: Heidrich, Isabel, et al.
Publicado: (2021)

Clinical significance of the De Ritis ratio for detecting prostate cancer in a repeat prostate biopsy
por: Ha, Heon, et al.
Publicado: (2019)

Prostatic chronic inflammation and prostate cancer risk at baseline random biopsy: Analysis of predictors
por: Tafuri, Alessandro, et al.
Publicado: (2020)

RNAs as Candidate Diagnostic and Prognostic Markers of Prostate Cancer—From Cell Line Models to Liquid Biopsies
por: Lim, Marvin C. J., et al.
Publicado: (2018)

Paradigm Shift in Prostate Cancer Diagnosis: Pre-Biopsy Prostate Magnetic Resonance Imaging and Targeted Biopsy
por: Park, Jung Jae, et al.
Publicado: (2022)

Prostate Cancer Liquid Biopsy Biomarkers’ Clinical Utility in Diagnosis and Prognosis
por: Matuszczak, Milena, et al.
Publicado: (2021)

The Severity of Pain in Prostate Biopsy Depends on the Biopsy Sector
por: Rempega, Grzegorz, et al.
Publicado: (2023)

Do Concomitant Systematic Biopsies Add to Fusion Targeted Biopsies in the Diagnosis and Management of Clinically Significant Prostate Cancer?
por: Thompson, Alice, et al.
Publicado: (2023)

Software-assisted US/MRI fusion-targeted biopsy for prostate cancer
por: Angileri, Salvatore Alessio, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_asc3niapkq6krtfjvuu5recrah